Using Remote Tracking to Detect and Deter Medications Theft in Malawi

How to cite

Carvalho, Mariana; Gibson, Clark; Seim, Brigitte; Jablonski, Ryan. 2018. "Using Remote Tracking to Detect and Deter Medications Theft in Malawi." AEA RCT Registry. AEARCTR-0003684. https://doi.org/10.1257/rct.3684-1.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Mariana Carvalho* , Clark Gibson , Brigitte Seim , Ryan Jablonski

* Primary investigator

Registry ID
AEARCTR-0003684
DOI
https://doi.org/10.1257/rct.3684-1.0
First registered
Last updated
Status
In development
Trial dates
2019-02-15 – 2019-06-30
Countries
Private
Registry record
http://www.socialscienceregistry.org/trials/3684

Abstract

This project seeks to identify how bottom-up community interventions and top-down audits change spatial patterns of medicinal drug diversion, impact access to public health aid, and perceptions of clinic accountability using a two-arm factorial randomized control trial. While firm estimates are lacking, medication theft is likely one of the leading causes of preventable disease in low income countries. According to Malawi Ministry of Health officials, 29% of spending on drugs and medical supplies disappears due to theft alone. Malawi is a particularly extreme outlier, but these estimates are not far off from estimates in other countries. We introduce a novel measurement protocol that allows to more precisely estimate these theft rates, and the impact of these interventions on drug theft across the supply chain.

Intervention

Studies of drug theft confront significant measurement difficulties that can impede appropriate policy designs: (1) identifying theft and distinguishing it from mismanagement or poor accounting is extremely difficult due to incentives for obfuscation; (2) identifying where in the supply chain theft occurs is not possible using most existing measurement protocols; and (3) the precise mechanisms linking policy interventions to outcomes are difficult to determine. We have designed our project to resolve these challenges. Our intervention involves two treatment arms:

1) The first treatment arm is a top-down government-led intervention involving the provision of information to clinic officials via posters. The information in the posters will convey that technology is being used to monitor drug deliveries in that specific clinic and the penalties for being discovered with stolen drugs.

2) The second intervention is a bottom-up community-led intervention that will improve the capacity of communities to monitor and hold officials accountable for drug theft. It will involve workshops with Health Centre Advisory Committees (HCACs) providing information regarding how to learn of drug delivery dates, drug availability, clinic responsibilities, and a reporting hotline. Committees will also receive a stipend for transport and communications costs for committee members to conduct site visits at the clinics.

Experimental design

We will randomly sample clinics within the Southern region of Malawi from a pre-existing list produced by the Ministry of Health. Two hundred (200) clinics will receive tracking medications measurement at endline. Our goal is to identify at what point in the medications supply chain is theft most common: in transit to clinics; at clinics at time of delivery; at clinics while in inventory; or after dissemination to patients. We propose two interventions to evaluate how the government can reduce the level of theft.

These 200 clinics will also receive baseline and endline surveys of government officials, Health Centre Advisory Committee members, and citizens in the area surrounding the clinic. At these same 200 clinics, we will collect baseline, midline, and endline data on the cost and availability of medications in private pharmacies and markets surrounding the clinics to investigate the effects of monitoring on welfare outcomes.

Design details

Randomization method
Randomization done in office by a computer.
Randomization unit
Clinics.
Clusters
200 Clinics.
Observations
We will monitor 30% of the drug cartons for deliveries to 200 clinics. We anticipate this will involve tracking 2400 cartons. For the patient health outcomes, our proposed sample size is 7,000 subjects (200 clinics x 35 subjects per clinic).
Arms
50 clinics "top-down" treatment 50 clinics "bottom-up" treatment 50 clinics "top-down and bottom-up" treatment 50 clinics pure control (no intervention)
Primary outcomes
Share of drug cartons per clinic delivery that fail to reach their destination. Share of cartons stolen upstream or downstream from a clinic
Secondary outcomes
Patient health outcomes, including access to drugs, cost of drugs, perceptions and knowledge of corruption, and perceived efficacy of anti-corruption efforts (by both citizens and government).

Cited by

No citation data available for this registration yet.

Keywords